Read news as it happens
Create a Rediffmail account
Get Rediff News delivered into your Inbox daily
Why IHH's takeover of Fortis may not be smooth
On Wednesday, Daiichi Sankyo's lawyers argued for a stay on stake sale by Fortis, which was opposed by counsels of...
Pfizer halts production at TN plant after 11 USFDA observations
Pfizer's manufacturing facility in Tamil Nadu's Sriperumbudur is not following quality control norms and lacks data...
From someone who knows: How to do well in business
'In any business you have to achieve short-term goals.' 'But at the same time you have to keep your broader...
Why Sunil Munjal is keen to acquire Fortis
According to Munjal, there is an opportunity for somebody who comes from a not for profit background in health care...
How Fortis Healthcare's fortunes will change post acquisition by IHH
In its investor presentation, IHH said it wanted to develop Fortis into a market leader.
Pharma industry bounces back to good health
In May, price growth for drugs was in negative territory at (-)1 per cent
'Whatever I have is because of India'
'15, 17 years back we were not even in existence in the US. Today nearly 1/3 of prescriptions written comes from...
Will this movie change China's drug policy towards India?
Dying To Survive, on its way to becoming China's biggest box office hit, may compel the Xi Jinping government to...
How India's young innovators do well by doing good
'Let me talk about young Indian startups with their hearts in the right place and how they are proving that...
What the future holds for Biocon
'The obvious opportunity is biosimilars, which are simpler but more expensive,' says Kiran Mazumdar-Shaw, founder of...
Office email App
© 2018 Rediff.com